Skip links
Companies
› United Kingdom › ROSLIN CELL THERAPIES LIMITED
ROSLIN CELL THERAPIES LIMITED logo

ROSLIN CELL THERAPIES LIMITED

Private limited company (Ltd.) Active

in

Registration No.
SC512315
Incorporation Date
2015-08-04
Company Type
Private limited company (Ltd.)
Address
EDINBURGH, United Kingdom
Website
www.roslinct.com/
Source: Companies House

ROSLIN CELL THERAPIES LIMITED is a Private limited company (Ltd.) registered in United Kingdom under SC512315, and its current status with Companies House is active. The company was incorporated on 4 August 2015 and lists its registered address as EDINBURGH, United Kingdom. 1 shareholder is on record for ROSLIN CELL THERAPIES LIMITED, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Companies House and was last updated on 8 October 2026.

Data Provenance
This record is sourced directly from official government registries, including Companies House.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

1

One shareholder is currently on record for ROSLIN CELL THERAPIES LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006.

The largest of these is DOLLY BIDCO LIMITED, holding 100% — a majority holding.

Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
DOLLY BIDCO LIMITED 100% Companies House

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

4

Four officers are currently on record for ROSLIN CELL THERAPIES LIMITED, filed with Companies House. Ian McCubbin (appointed 2018-11-09), Geoffrey Hamilton-Fairley (appointed 2021-12-14), Andrea Ponti (appointed 2021-12-14) and Peter Coleman (appointed 2022-09-02) all serve as Director.

The register reports 21 officers in total, including past appointments, though only the 4 most relevant records are shown here.

Management authority at ROSLIN CELL THERAPIES LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

IM
Ian McCubbin ACTIVE

Appointed
2018-11-09
Residence
🇬🇧 United Kingdom
Occupation
Director

GH
Geoffrey Hamilton-Fairley ACTIVE

Appointed
2021-12-14
Residence
🇬🇧 United Kingdom
Occupation
Director

AP
Andrea Ponti ACTIVE

Appointed
2021-12-14
Residence
🇬🇧 United Kingdom
Occupation
Director

PC
Peter Coleman ACTIVE

Appointed
2022-09-02
Residence
🇬🇧 United Kingdom
Occupation
Director

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

ROSLIN CELL THERAPIES LIMITED sits 4 levels below its ultimate parent, DOLLY TOPCO (JERSEY) LIMITED, registered in United Kingdom. Immediately above ROSLIN CELL THERAPIES LIMITED is DOLLY BIDCO LIMITED, holding 100% as filed in ROSLIN CELL THERAPIES LIMITED's own shareholder record with Companies House. DOLLY TOPCO (JERSEY) LIMITED sits further up the chain, a link derived by walking shareholder filings across jurisdictions rather than stated in a single document.

Ultimate HQ
DOLLY TOPCO (JERSEY) LIMITED
United Kingdom

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on ROSLIN CELL THERAPIES LIMITED?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns ROSLIN CELL THERAPIES LIMITED?

One shareholder is currently on record for ROSLIN CELL THERAPIES LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is DOLLY BIDCO LIMITED, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is ROSLIN CELL THERAPIES LIMITED's UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for ROSLIN CELL THERAPIES LIMITED is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does ROSLIN CELL THERAPIES LIMITED have on record?

1 shareholder is shown on record for ROSLIN CELL THERAPIES LIMITED.

What is ROSLIN CELL THERAPIES LIMITED's company registration number?

ROSLIN CELL THERAPIES LIMITED's registration number is SC512315, filed with Companies House in United Kingdom. Its current status on the register is active.

Is ROSLIN CELL THERAPIES LIMITED still an active company?

ROSLIN CELL THERAPIES LIMITED's status on Companies House is listed as active.

When was ROSLIN CELL THERAPIES LIMITED incorporated?

ROSLIN CELL THERAPIES LIMITED was incorporated on 4 August 2015, according to Companies House.

What is ROSLIN CELL THERAPIES LIMITED's registered address?

The registered address on file for ROSLIN CELL THERAPIES LIMITED is EDINBURGH, United Kingdom.

What legal structure is ROSLIN CELL THERAPIES LIMITED registered as?

ROSLIN CELL THERAPIES LIMITED is registered as a Private limited company (Ltd.) in United Kingdom.

Who are the officers/directors of ROSLIN CELL THERAPIES LIMITED?

Four officers are currently on record for ROSLIN CELL THERAPIES LIMITED, filed with Companies House. Ian McCubbin (appointed 2018-11-09), Geoffrey Hamilton-Fairley (appointed 2021-12-14), Andrea Ponti (appointed 2021-12-14) and Peter Coleman (appointed 2022-09-02) all serve as Director. Management authority at ROSLIN CELL THERAPIES LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does ROSLIN CELL THERAPIES LIMITED have a parent company or subsidiaries?

ROSLIN CELL THERAPIES LIMITED sits 4 levels below its ultimate parent, DOLLY TOPCO (JERSEY) LIMITED, registered in United Kingdom.

Can Zavia monitor changes to ROSLIN CELL THERAPIES LIMITED's ownership over time?

This profile reflects a point-in-time snapshot from Companies House. Zavia's monitoring API can track changes to ROSLIN CELL THERAPIES LIMITED's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access ROSLIN CELL THERAPIES LIMITED's data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United Kingdom, so records like ROSLIN CELL THERAPIES LIMITED's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from Companies House and was last synced on 8 October 2026.

This website uses cookies to improve your web experience.